Learn about the relationship between Penn Medicine and CHOP which benefits patients with familial cardiomyopathy
The Penn Medicine-CHOP Partnership
Penn Medicine has partnered with the Children's Hospital of Philadelphia (CHOP) to create a special program for patients with inherited cardiomyopathies. Through the Penn Center for Inherited Cardiac Disease, teams from Penn Medicine and CHOP work together to ensure that patients and their entire families receive the best care possible.
How the Partnership Works
CHOP to Penn
After a child is diagnosed with a cardiomyopathy at CHOP, the pediatric cardiologist may recommend that parents and, in some cases other adult family members, see an adult cardiologist at the Penn Heart and Vascular Center at the Ruth and Raymond Perelman Center for Advanced Medicine.
The appointment at Penn Medicine includes a detailed history, physical exam, electrocardiogram and echocardiogram to help the cardiologist determine whether the any of the adult family members have a cardiomyopathy. Appropriate treatment is then started for any adults found to have a cardiomyopathy. If no cardiomyopathy is found, the family members may need to visit the cardiologist every few years for a checkup, because cardiomyopathies can develop over time. Genetic counselors are available to provide genetic counseling and, in some cases, genetic testing.
Penn to CHOP
The first appointment includes a detailed history, a physical exam, an electrocardiogram and an echocardiogram to help the cardiologist determine whether the child has a cardiomyopathy. If the child is found to have a cardiomyopathy, a CHOP cardiologist provides care. If the child shows no evidence of a cardiomyopathy, he or she may need to visit the cardiologist for checkups every one to three years until adult age, since cardiomyopathies can develop with age.
In some cases, blood tests can show if family members carry gene differences that may cause cardiomyopathies. Genetic counselors at CHOP can answer the questions families often have, how the cardiomyopathy gene is passed to children and the risk of other or future children for developing the disease.